Brief: Advent Strikes €4.1Bn Deal To Sell Generic Drugmaker Zentiva To GTCR - FT
11/09/2025 04:07
Sept 10 (Reuters) - ADVENT STRIKES €4.1BN DEAL TO SELL GENERIC DRUGMAKER ZENTIVA TO GTCR - FT Source text: https://tinyurl.com/3xxawd76 Further company coverage: 1SKF401E.BV ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zentiva as
See all newsBrief: Zentiva Publishes 2025 Sustainability Report Reinforcing Commitment To People, Partners And The Planet.
Brief: Zentiva As - Responds To EU Court Decision On Uwwtd
Media: Wall Street, private debt prep 3.6 billion euros on GTCR Zentiva deal- Bloomberg News
Private equity firm Advent to sell generic drugmaker Zentiva to GTCR (updated)
Deals of the Day-Mergers and acquisitions